|
| Press Releases |
|
 |
|
| Friday, August 19, 2022 |
|
|
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY |
| Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. more info >> |
|
| Monday, August 15, 2022 |
|
|
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully |
| On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. more info >> |
|
| Tuesday, August 9, 2022 |
|
|
Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully |
| On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. more info >> |
|
| Monday, August 8, 2022 |
|
|
New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B |
| Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B round of fundraising with over RMB 300 million, which is backed by Legend Capital. more info >> |
|
| Thursday, July 28, 2022 |
|
|
Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A Financing |
| Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as "AKA Robotics"), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital. more info >> |
|
| Thursday, July 21, 2022 |
|
|
Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Successfully |
| On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on the KOSDAQ market. more info >> |
|
| Thursday, July 7, 2022 |
|
|
Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB |
| Jiangsu Huili Biotechnology Co., Ltd ("Huili Bio"), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB. more info >> |
|
| Thursday, June 16, 2022 |
|
|
Legend Capital Increases Carbon Neutrality Investments: Portfolio Company Talent New Energy Completes A++ Financing Round with Several Hundred Million RMB |
| Legend Capital's portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion of its Series A++ financing round with several hundred million RMB. more info >> |
|
| Wednesday, June 15, 2022 |
|
|
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM |
| On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen (bevacizumab biosimilar) more info >> |
|
| Thursday, June 9, 2022 |
|
|
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange |
| On June 8th 2022, Legend Capital's portfolio company ANYCOLOR, a leading Virtual YouTuber (VTuber) management company in Japan, was listed on the Tokyo Stock Exchange. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
Feb 25, 2026 21:59: JST
|
|
|
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
Feb 25, 2026 20:59 HKT/SGT
|
|
|
雲頂新耀股東特別大會通過商業化服務協議等決議案
Feb 25, 2026 20:59 HKT/SGT
|
|
|
云顶新耀股东特别大会通过商业化服务协议等决议案
Feb 25, 2026 20:59 HKT/SGT
|
|
|
Doubleview Gold Corp. Reports Updated Mineral Resource Estimate as of February 25, 2026 Including a Copper Equivalent Mineral Resource: 609 (Mt) of Measured and Indicated Resources at 0.43% CuEq containing CuEq 5.82 Billion lbs. 503 (Mt) of Inferred Resources at 0.41% CuEq containing CuEq 4.57 Billion lbs
Feb 25, 2026 20:59 HKT/SGT
|
|
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 25, 2026 19:57 HKT/SGT
|
|
|
DOCOMO Successfully Demonstrates AI Application Operation Using Virtualized Radio Access Network (vRAN) Infrastructure
Feb 25, 2026 20:50 JST
|
|
|
DOCOMO Begins Commercial Deployment of Agentic AI System for Network Maintenance Using One of the World's Largest Datasets
Feb 25, 2026 20:40 JST
|
|
|
Champion REIT Delivers Resilient Performance, Proactive Tenant Mix Optimisation Drives Sustainable Development
Feb 25, 2026 19:30 HKT/SGT
|
|
|
冠君產業信託於挑戰中彰顯韌性 積極優化租戶組合推動持續發展
Feb 25, 2026 19:30 HKT/SGT
|
|
|
周大福人壽支持《財政預算案》有關跨境安老、落實《香港可持續披露準則》以及推動體育普及化、盛事化等措施
Feb 25, 2026 18:07 HKT/SGT
|
|
|
HKTDC welcomes the 2026-27 Budget
Feb 25, 2026 17:29 HKT/SGT
|
|
|
NEC Implements AI Code Review Service "Metabob," Reducing Technical Verification Time by Up to 66%
Feb 25, 2026 18:00 JST
|
|
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Shoucheng Holdings (00697.HK) Sees Long-Term International Capital Rotation as Robotics Portfolio Enters Harvest Phase
Feb 25, 2026 12:23 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
